ACMI - Accumed Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sigmund who wrote (706)	12/18/1997 12:43:00 AM
From: Cisco	Read Replies (1) of 1894

Sigmund, I think there is some confusion on which systems can read ThinPrep. It has been reported on the Motley Fool that Papnet is not designed to read ThinPrep: fool.yahoo.com In a press release last year it was reported that AutoPap could read ThinPrep: businesswire.com Whether something has occured since then that has changed that assumption, I don't know. Kinda funny they haven't mention it since? Also, I am not sure whether an additional FDA approval would be needed for AutoPap to read ThinPrep or not. I would assume it would especially as a Primary Screener. In a recent press release from AccuMed, it has been reported that TracCell can read ThinPrep: accumed.com I believe the reason that all the analyst have gone to a hold recommendation on NPTH is because NPTH is a one product company whose entire stock price depends upon the outcome of Jan. 28, 1998. My gut feeling is that it probably will get panel approval, but there are several on this thread that would strongly disagree with me on that. Many believe that FDA will drag its feet and be slow to approve a Primary Screener. I assume that even if it gets panel approval, it still has to wait for full approval from the FDA. Do you know? You may also be interested in the Proposed Guidlines for Primary Screening Instruments for Gynecologic Cytology: cytopathology.org I would encourage you to take a close look at AccuMed. I believe we will see ACMI selling for at least $5.50 sometime next year. That would be a 283% return. NPTH would have to sell for $41.21 to give you that same percentage return. I believe we will see ACMI at $5.50 long before we will see NPTH at $41.21. I didn't know whether you have seen the above links or not, this may be old news to you. Good luck. Cisco

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next